185 related articles for article (PubMed ID: 36036470)
1. Lung Cancer Treatment Advances in 2022.
Abu Rous F; Singhi EK; Sridhar A; Faisal MS; Desai A
Cancer Invest; 2023 Jan; 41(1):12-24. PubMed ID: 36036470
[TBL] [Abstract][Full Text] [Related]
2. Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reports.
Lai L; Meng W; Wei J; Zhang X; Tan Z; Lu Y; Hou E
Medicine (Baltimore); 2021 Mar; 100(10):e25046. PubMed ID: 33725888
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lung cancer.
Gadgeel SM; Ramalingam SS; Kalemkerian GP
Radiol Clin North Am; 2012 Sep; 50(5):961-74. PubMed ID: 22974781
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
[TBL] [Abstract][Full Text] [Related]
5. Recent clinical advances in lung cancer management.
Johnson DH; Schiller JH; Bunn PA
J Clin Oncol; 2014 Apr; 32(10):973-82. PubMed ID: 24567433
[TBL] [Abstract][Full Text] [Related]
6. [Combined-modality therapy for lung cancer].
Miura S; Yamamoto N
Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
[TBL] [Abstract][Full Text] [Related]
7. [Research Progress of Immunotherapy and Prognostic Markers in Small Cell Lung Cancer].
Wang Q; Peng W; Jiang M; Wu L
Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):182-188. PubMed ID: 32102135
[TBL] [Abstract][Full Text] [Related]
8. New Therapies and Biomarkers: Are We Ready for Personalized Treatment in Small Cell Lung Cancer?
Zhang B; Birer SR; Dvorkin M; Shruti J; Byers L
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-10. PubMed ID: 33979194
[TBL] [Abstract][Full Text] [Related]
9. Transformational Changes Between Non-Small Cell and Small Cell Lung Cancer-Biological and Clinical Relevance-A Review.
Clamon G; Zeitler W; An J; Hejleh TA
Am J Clin Oncol; 2020 Sep; 43(9):670-675. PubMed ID: 32889839
[TBL] [Abstract][Full Text] [Related]
10. Lung Cancer: Management.
Mott TF
FP Essent; 2018 Jan; 464():27-30. PubMed ID: 29313655
[TBL] [Abstract][Full Text] [Related]
11. Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology.
Mirshahidi HR; Hsueh CT
J Hematol Oncol; 2010 May; 3():18. PubMed ID: 20433767
[TBL] [Abstract][Full Text] [Related]
12. Tumour volume changes assessed with high-quality KVCT in lung cancer patients undergoing concurrent chemoradiotherapy.
Lee YH; Kim YS; Lee HC; Lee SW; Kang YN; Kang JH; Hong SH; Kim YK; Kim SJ; Ahn MI; Han DH; Yoo IR; Park JG; Sung SW; Lee KY
Br J Radiol; 2015 Aug; 88(1052):20150156. PubMed ID: 26055505
[TBL] [Abstract][Full Text] [Related]
13. Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer.
Rice SJ; Belani CP
PLoS One; 2021; 16(12):e0260988. PubMed ID: 34855926
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation.
Santoni-Rugiu E; Grauslund M; Melchior LC; Costa JC; Sørensen JB; Urbanska EM
Lung Cancer; 2017 Nov; 113():14-17. PubMed ID: 29110841
[TBL] [Abstract][Full Text] [Related]
15. Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer.
Tokaca N; Wotherspoon A; Nicholson AG; Fotiadis N; Thompson L; Popat S
Lung Cancer; 2017 Sep; 111():65-68. PubMed ID: 28838401
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.
Du L; Schageman JJ; Irnov ; Girard L; Hammond SM; Minna JD; Gazdar AF; Pertsemlidis A
J Exp Clin Cancer Res; 2010 Jun; 29(1):75. PubMed ID: 20624269
[TBL] [Abstract][Full Text] [Related]
17. Origins, genetic landscape, and emerging therapies of small cell lung cancer.
Semenova EA; Nagel R; Berns A
Genes Dev; 2015 Jul; 29(14):1447-62. PubMed ID: 26220992
[TBL] [Abstract][Full Text] [Related]
18. [Lung cancer: an update in 2010].
Besse B; Vignot S; Soria JC
Bull Cancer; 2010 Jan; 97(1):161-9. PubMed ID: 20028651
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
20. New insights into small-cell lung cancer development and therapy.
Wang Y; Zou S; Zhao Z; Liu P; Ke C; Xu S
Cell Biol Int; 2020 Aug; 44(8):1564-1576. PubMed ID: 32281704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]